نتائج البحث - Waylan Bessler

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood

    Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood حسب Munaza Javed, Laura E. Mead, Daniel N. Prater, Waylan Bessler, David Foster, Jamie Case, W. Scott Goebel, Mervin C. Yöder, Laura S. Haneline, David A. Ingram

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans

    Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans حسب Elisabeth A. Lasater, Fang Li, Waylan Bessler, Myka L. Estes, Sasidhar Vemula, Cynthia M. Hingtgen, Mary C. Dinauer, Reuben Kapur, Simon J. Conway, David A. Ingram

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors

    Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors حسب Jamie Case, Laura E. Mead, Waylan Bessler, Daniel N. Prater, Hilary White, M. Reza Saadatzadeh, Janak R. Bhavsar, Mervin C. Yöder, Laura S. Haneline, David A. Ingram

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/− mast cells

    Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/− mast cells حسب Andrew S. McDaniel, Jayme D. Allen, Su-Jung Park, Zahara M. Jaffer, Elizabeth G. Michels, Sarah J. Burgin, Shi Chen, Waylan Bessler, Clemens Hofmann, David A. Ingram, Jonathan Chernoff, D. Wade Clapp

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation

    Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation حسب Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Jiang Li, Qingbo Lu, Julie A. Mund, Xiaohong Li, Waylan Bessler, Shaomin Qian, William E. Dyer, George E. Sandusky, Andrew Horvai, Amy E. Armstrong, D. Wade Clapp

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics

    p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics حسب Jayme D. Allen, Zahara M. Jaffer, Su-Jung Park, Sarah J. Burgin, Clemens Hofmann, Mary Ann Sells, Shi Chen, Ethel Derr‐Yellin, Elizabeth G. Michels, Andrew S. McDaniel, Waylan Bessler, David A. Ingram, Simon J. Atkinson, Jeffrey B. Travers, Jonathan Chernoff, D. Wade Clapp

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial حسب Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK حسب Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, Marc Ferrer, Steven P. Angus, Eric Hawley, Alejandra M. Petrilli, Roberta L. Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan Bessler, Xiaohu Zhang, Rajarshi Guha, Craig J. Thomas, Sarah S. Burns, Thomas S.K. Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A.H. Dixon, Andrea R. Masters, David R. Jones, Charles W. Yates, Stephen J. Haggarty, Salvatore La Rosa, D. Bradley Welling, Anat Stemmer‐Rachamimov, Scott R. Plotkin, James F. Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernández‐Valle, Gary L. Johnson, Jaishri O. Blakeley, D. Wade Clapp

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: